Literature DB >> 16380684

Early effects of treatment on regional cerebral blood flow in first episode schizophrenia patients evaluated with 99Tc-ECD-SPECT.

Brigita Novak1, Metka Milcinski, Marko Grmek, Margareta Kocmur.   

Abstract

OBJECTIVES: Altered regional cerebral blood flow (r-CBF) is mentioned as one of possible etiological factors or as a consequence of schizophrenia. Perfusion scintigraphic brain studies with SPECT (Single Photon Emission Computed Tomography) and PET (Positron Emission Tomography) can detect areas of the brain with altered perfusion during the disease. Conflicting data exist on follow-up after treatment. The aim of our study was to evaluate r-CBF in acute first-episode schizophrenia and early effect of antipsychotic drugs on r-CBF. DESIGN AND
SETTING: Clinical criteria for schizophrenia were met according to International Classification of Diseases-10th Edition (ICD-10). Psychic status and severity of the disease in each patient were evaluated with psychiatric interview, Positive and Negative Syndrome Scale (PANSS) and Clinical Global Impression (CGI) on the same day as the scintigraphic study. Brain perfusion SPECT was performed 20 minutes after 99mTc-ECD application. R-CBF was measured in 9 first-episode schizophrenic male patients 2-7 (median 6) days after the beginning of antipsychotic treatment and 8-15 (median 9) weeks later. Semiquantitative analysis of r-CBF was performed with cerebellum as the reference region. R-CBF was evaluated for 12 regions in each study.
RESULTS: Decrease in perfusion in comparison to cerebellum was detected in left (90%) and right (93%) frontal lobes. Increase in perfusion between the first (t1) and the second (t2) investigation was significant (p<0.05) for both frontal regions (left 94%, right 97%). Significant decrease in PANSS (p<0.05) and CGI (p<0.001) scores was noted and correlated well with the increase of r-CBF.
CONCLUSIONS: Our findings implicate that patients with first-episode schizophrenia have significant left hypoperfusion relative to the right in dorsolateral frontal lobes. Increased blood flow was observed bilaterally in dorsolateral frontal lobes after 10 weeks of antipsychotic medication. Significant amelioration of r-CBF correlated with clinical improvement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16380684

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  5 in total

1.  Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trial.

Authors:  Arthur L Brody; Alexey G Mukhin; Michael S Mamoun; Trinh Luu; Meaghan Neary; Lidia Liang; Jennifer Shieh; Catherine A Sugar; Jed E Rose; Mark A Mandelkern
Journal:  JAMA Psychiatry       Date:  2014-07-01       Impact factor: 21.596

2.  Increased hippocampal blood volume and normal blood flow in schizophrenia.

Authors:  Pratik Talati; Swati Rane; Jack Skinner; John Gore; Stephan Heckers
Journal:  Psychiatry Res       Date:  2015-04-03       Impact factor: 3.222

3.  Comparison of Acute Followed by Maintenance ECT vs Clozapine on Psychopathology and Regional Cerebral Blood Flow in Treatment-Resistant Schizophrenia: A Randomized Controlled Trial.

Authors:  Biswa Ranjan Mishra; Kanhaiyalal Agrawal; Tathagata Biswas; Debadatta Mohapatra; Santanu Nath; Rituparna Maiti
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

Review 4.  Brain perfusion single photon emission computed tomography in major psychiatric disorders: From basics to clinical practice.

Authors:  Amburanjan Santra; Rakesh Kumar
Journal:  Indian J Nucl Med       Date:  2014-10

5.  Effect of Deep Brain Stimulation on Regional Cerebral Blood Flow in Patients with Medically Refractory Tourette Syndrome.

Authors:  Cathleen Haense; Kirsten R Müller-Vahl; Florian Wilke; Christoph Schrader; Holger H Capelle; Lilli Geworski; Frank M Bengel; Joachim K Krauss; Georg Berding
Journal:  Front Psychiatry       Date:  2016-07-05       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.